[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:testosterone":3},{"name":4,"total":5,"recruiting":6,"trials":7},"Testosterone",28,23,[8,16,22,28,34,40,46,52,58,64,70,76,83,90,96,102,108,114,120,126,132,139,145,151,158,164,169,176],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05915442","Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer",[12],"Phase 2","RECRUITING","2026-08-26T02:16:46.951087Z","2026-05-05T02:43:29.710200Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06067269","Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial",[12],"2026-08-26T02:16:57.705506Z","2026-05-05T02:43:29.699425Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT07025369","Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET\u002FCT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial",[12],"2026-08-26T02:18:05.435729Z","2026-05-05T02:43:29.508161Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":32,"content_modified":33},"NCT06824818","Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients",[],"2026-08-26T02:16:02.918558Z","2026-05-05T02:43:29.394033Z",{"nct_id":35,"title":36,"phases":37,"status":13,"updated_at":38,"content_modified":39},"NCT04798469","Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism",[12],"2026-08-26T02:16:16.169331Z","2026-05-05T02:43:29.218498Z",{"nct_id":41,"title":42,"phases":43,"status":13,"updated_at":44,"content_modified":45},"NCT06397703","ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer",[12],"2026-08-26T02:17:36.611194Z","2026-05-05T02:43:28.336875Z",{"nct_id":47,"title":48,"phases":49,"status":13,"updated_at":50,"content_modified":51},"NCT06111313","The University of Miami Adapt (UAdapt) Trial",[12],"2026-08-26T02:18:21.216897Z","2026-05-05T02:43:27.857905Z",{"nct_id":53,"title":54,"phases":55,"status":13,"updated_at":56,"content_modified":57},"NCT05249634","Testosterone Treatment in Men with Chronic Kidney Disease",[12],"2026-08-26T02:16:13.426928Z","2026-05-05T02:35:31.614061Z",{"nct_id":59,"title":60,"phases":61,"status":13,"updated_at":62,"content_modified":63},"NCT06993155","A Clinical Trial Evaluating the Efficacy and Safety of Leflutrozole on Testicular Function",[12],"2026-08-26T02:19:13.549512Z","2026-04-29T02:57:57.077376Z",{"nct_id":65,"title":66,"phases":67,"status":13,"updated_at":68,"content_modified":69},"NCT07354919","Axelopran in Advanced Cancers",[12],"2026-08-26T02:16:17.877565Z","2026-05-05T02:43:27.129300Z",{"nct_id":71,"title":72,"phases":73,"status":13,"updated_at":74,"content_modified":75},"NCT04349059","The Impact of Dietary Pattern on Erectile Function",[],"2026-08-26T02:19:23.493898Z","2026-05-05T02:43:29.702658Z",{"nct_id":77,"title":78,"phases":79,"status":13,"updated_at":81,"content_modified":82},"NCT05521698","A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer",[80],"Phase 1","2026-08-26T02:17:23.750999Z","2026-05-05T02:35:31.758977Z",{"nct_id":84,"title":85,"phases":86,"status":13,"updated_at":88,"content_modified":89},"NCT06813898","An Investigational Scan (rhPSMA-7.3 PET\u002FCT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial",[87],"Early Phase 1","2026-08-26T02:16:38.897933Z","2026-05-05T02:43:26.925501Z",{"nct_id":91,"title":92,"phases":93,"status":13,"updated_at":94,"content_modified":95},"NCT03986021","Reproductive Axis Maturation in the Early Post-Menarchal Years",[],"2026-08-26T02:15:58.452248Z","2026-05-13T02:55:06.184042Z",{"nct_id":97,"title":98,"phases":99,"status":13,"updated_at":100,"content_modified":101},"NCT07227740","Testosterone Deficiency and Endothelial Dysfunction After Spinal Cord Injury",[],"2026-08-26T02:16:34.792807Z","2026-05-13T02:55:06.680525Z",{"nct_id":103,"title":104,"phases":105,"status":13,"updated_at":106,"content_modified":107},"NCT06583408","The REgistry of Very Early Estrogen and AnovuLation",[],"2026-08-26T02:17:07.954622Z","2026-05-13T02:55:06.555667Z",{"nct_id":109,"title":110,"phases":111,"status":13,"updated_at":112,"content_modified":113},"NCT04723862","Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism?",[87],"2026-08-26T02:17:49.709549Z","2026-05-05T02:43:27.663586Z",{"nct_id":115,"title":116,"phases":117,"status":13,"updated_at":118,"content_modified":119},"NCT06682390","Role of Race in Nutritional Approach in Men on ADT",[],"2026-08-26T02:17:46.653867Z","2026-05-05T02:43:27.324891Z",{"nct_id":121,"title":122,"phases":123,"status":13,"updated_at":124,"content_modified":125},"NCT06414096","Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome",[80],"2026-08-26T02:18:38.865010Z","2026-05-05T02:43:27.098353Z",{"nct_id":127,"title":128,"phases":129,"status":13,"updated_at":130,"content_modified":131},"NCT04460872","Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury",[12],"2026-08-26T02:15:50.539717Z","2026-05-05T02:43:26.749785Z",{"nct_id":133,"title":134,"phases":135,"status":13,"updated_at":137,"content_modified":138},"NCT06455969","Adaptions and Resiliency to Multi-Stressor OpeRations",[136],"Phase 4","2026-08-26T02:19:29.119921Z","2026-04-29T02:57:57.122982Z",{"nct_id":140,"title":141,"phases":142,"status":13,"updated_at":143,"content_modified":144},"NCT03068910","Hyperandrogenemia and Altered Day-night LH Pulse Patterns",[87],"2026-08-26T02:18:20.384845Z","2026-05-05T02:43:28.011685Z",{"nct_id":146,"title":147,"phases":148,"status":13,"updated_at":149,"content_modified":150},"NCT00929006","Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism",[87],"2026-08-26T02:15:00.557154Z","2026-05-05T02:43:27.053388Z",{"nct_id":152,"title":153,"phases":154,"status":155,"updated_at":156,"content_modified":157},"NCT06660862","Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.",[136],"NOT_YET_RECRUITING","2026-08-26T02:17:43.321968Z","2026-05-05T02:43:28.880266Z",{"nct_id":159,"title":160,"phases":161,"status":155,"updated_at":162,"content_modified":163},"NCT06082817","An Open-Label Study of 50 Mg Oral Testosterone Undecanoate (Kyztrex) in Menopausal Women with Low Testosterone and HSDD",[12],"2026-08-26T02:19:03.581490Z","2026-04-29T02:57:57.081316Z",{"nct_id":165,"title":166,"phases":167,"status":155,"updated_at":124,"content_modified":168},"NCT04601233","Testosterone Treatment for Erectile Dysfunction and Multiple Sclerosis",[136],"2026-04-29T02:57:57.077596Z",{"nct_id":170,"title":171,"phases":172,"status":173,"updated_at":174,"content_modified":175},"NCT06206746","The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System",[],"ACTIVE_NOT_RECRUITING","2026-08-03T02:59:02.155507Z","2026-05-05T02:43:28.130021Z",{"nct_id":177,"title":178,"phases":179,"status":173,"updated_at":180,"content_modified":181},"NCT04301765","Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency",[12],"2026-08-03T02:31:37.197247Z","2026-05-05T02:43:29.667690Z"]